User profiles for Jean-Mathieu Beauregard
 | Jean-Mathieu BeauregardAssociate Professor of Nuclear Medicine, Université Laval Verified email at crchudequebec.ulaval.ca Cited by 3551 |
[HTML][HTML] Quantitative 177Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system
JM Beauregard, MS Hofman, JM Pereira, P Eu… - Cancer …, 2011 - ncbi.nlm.nih.gov
Purpose: The combination of single photon emission computed tomography (SPECT) and
computer tomography (CT) that incorporates iterative reconstruction algorithms with …
computer tomography (CT) that incorporates iterative reconstruction algorithms with …
The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy
JM Beauregard, MS Hofman, G Kong… - European journal of …, 2012 - Springer
Purpose Tumour sequestration of radiotracer may lead to decreased bioavailability in
healthy tissue resulting in lower absorbed radiation dose to critical organs. This study aims to …
healthy tissue resulting in lower absorbed radiation dose to critical organs. This study aims to …
Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial
…, LO Bouchard, A Beaulieu, JM Beauregard - European journal of …, 2019 - Springer
Purpose Peptide receptor radionuclide therapy (PRRT) is mostly administered using a fixed
injected activity (IA) per cycle. This empiric regime results in highly variable absorbed doses …
injected activity (IA) per cycle. This empiric regime results in highly variable absorbed doses …
Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study
M Del Prete, FA Buteau, JM Beauregard - European journal of nuclear …, 2017 - Springer
Purpose Peptide receptor radionuclide therapy (PRRT) with 177 Lu-octreotate is commonly
administered at empiric, fixed amounts of injected radioactivity (IA). This results in highly …
administered at empiric, fixed amounts of injected radioactivity (IA). This results in highly …
68Ga PET/CT ventilation–perfusion imaging for pulmonary embolism: a pilot study with comparison to conventional scintigraphy
MS Hofman, JM Beauregard, TW Barber… - Journal of Nuclear …, 2011 - Soc Nuclear Med
Ventilation–perfusion (V/Q) scintigraphy is established for regional assessment of lung
function in a variety of diseases, including pulmonary embolism (PE). PET/CT may further …
function in a variety of diseases, including pulmonary embolism (PE). PET/CT may further …
An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT/CT imaging
Purpose: To create an accurate map of the distribution of radiation dose deposition in
healthy and target tissues during radionuclide therapy. Methods: Serial quantitative SPECT/CT …
healthy and target tissues during radionuclide therapy. Methods: Serial quantitative SPECT/CT …
Health-related quality of life and pain outcomes with [177Lu] Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant …
…, XX Wei, VS Koshkin, JM Beauregard… - The Lancet …, 2023 - thelancet.com
Background In VISION, the prostate-specific membrane antigen (PSMA)-targeted radioligand
therapy lutetium-177 [ 177 Lu]Lu-PSMA-617 (vipivotide tetraxetan) improved radiographic …
therapy lutetium-177 [ 177 Lu]Lu-PSMA-617 (vipivotide tetraxetan) improved radiographic …
[HTML][HTML] PSMA theranostics: current landscape and future outlook
H Zhang, S Koumna, F Pouliot, JM Beauregard… - Cancers, 2021 - mdpi.com
Simple Summary The prognosis for metastatic prostate cancer patients remains poor.
Prostate-specific membrane antigen (PSMA) is overexpressed in prostate cancer and is a …
Prostate-specific membrane antigen (PSMA) is overexpressed in prostate cancer and is a …
[HTML][HTML] Accuracy of 177Lu activity quantification in SPECT imaging: a phantom study
…, J Tanguay, M Gonzalez, E Gaudin, JM Beauregard… - EJNMMI physics, 2017 - Springer
Background The aim of the study is to assess accuracy of activity quantification of 177 Lu
studies performed according to recommendations provided by the committee on Medical …
studies performed according to recommendations provided by the committee on Medical …
[HTML][HTML] Accuracy and reproducibility of simplified QSPECT dosimetry for personalized 177Lu-octreotate PRRT
…, W Zhao, FA Buteau, A Celler, JM Beauregard - EJNMMI physics, 2018 - Springer
Background Routine dosimetry is essential for personalized 177 Lu-octreotate peptide receptor
radionuclide therapy (PRRT) of neuroendocrine tumors (NETs), but practical and robust …
radionuclide therapy (PRRT) of neuroendocrine tumors (NETs), but practical and robust …